These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34072586)

  • 1. One Week of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver.
    Sugasawa T; Ono S; Yonamine M; Fujita SI; Matsumoto Y; Aoki K; Nakano T; Tamai S; Yoshida Y; Kawakami Y; Takekoshi K
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
    Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
    Heintz MM; McRee R; Kumar R; Baldwin WS
    PLoS One; 2020; 15(3):e0229896. PubMed ID: 32155178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
    Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
    Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet.
    Dungubat E; Watabe S; Togashi-Kumagai A; Watanabe M; Kobayashi Y; Harada N; Yamaji R; Fukusato T; Lodon G; Sevjid B; Takahashi Y
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33353230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
    Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways.
    Suzuki-Kemuriyama N; Abe A; Nakane S; Uno K; Ogawa S; Watanabe A; Sano R; Yuki M; Miyajima K; Nakae D
    FEBS Open Bio; 2021 Nov; 11(11):2950-2965. PubMed ID: 34390210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
    PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice.
    Susutlertpanya W; Wakuda H; Otani N; Kuramoto T; Li L; Kuranari M; Sekiguchi A; Kudo H; Uchida T; Imai H; Uemura N
    Life Sci; 2019 Jul; 228():251-257. PubMed ID: 31078545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis.
    Lee C; Kim J; Han J; Oh D; Kim M; Jeong H; Kim TJ; Kim SW; Kim JN; Seo YS; Suzuki A; Kim JH; Jung Y
    Nat Commun; 2022 Jan; 13(1):578. PubMed ID: 35102146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Analysis of Mitochondrial Function in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis Mouse Model.
    Yamada A; Watanabe A; Nara A; Ishimaru N; Maeda K; Ido Y; Kotake K; Asano M; Shinohara Y; Yamamoto T
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CDAHFD-induced mouse model mimicking human NASH in the metabolism of hepatic phosphatidylcholines and acyl carnitines.
    Yang J; Dai M; Wang Y; Yan Z; Mao S; Liu A; Lu C
    Food Funct; 2024 Mar; 15(6):2982-2995. PubMed ID: 38411344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease.
    Toita R; Kang JH
    Toxicol Lett; 2020 Oct; 332():1-6. PubMed ID: 32579995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
    Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
    J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-restricted feeding has a limited effect on hepatic lipid accumulation, inflammation and fibrosis in a choline-deficient high-fat diet-induced murine NASH model.
    Sato T; Oishi K
    PLoS One; 2024; 19(1):e0296950. PubMed ID: 38285666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
    Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
    World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
    Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH).
    Yasuda D; Torii H; Shimizu R; Hiraoka Y; Kume N
    Biol Pharm Bull; 2020; 43(4):616-618. PubMed ID: 32238704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.